Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Labetalol on Human Cocaine Use
NCT00000291Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Oct 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of labetalol in cocaine dependence, sponsored by National Institute on Drug Abuse. Primary endpoints: Subjective response to cocaine, Heart Rate and 1 more. Started Oct 1997; status: completed.
02
Drugs
labetalol
03
Conditions
cocaine dependence
Beyond the preview
Go deeper on NCT00000291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000291.